Antimicrobial Agents and Chemotherapy · 2003 · 24 citations · 9 references
MedicinePharmacokineticsPharmacologyAntimicrobial PharmacologyAntimicrobial PharmacotherapyClinical PharmacologyAntimicrobial DosingAntimicrobial Penetration Into TissuesPharmacokinetics Of AntimicrobialsSkin SafetyCutaneous BlisteringDeep Soft Tissue InfectionsEliminationSkin Infection Treatment
The pharmacokinetic disposition of meropenem, administered at 500 mg every 8 h, in plasma and cantharidin-induced blister fluid is described. Peak meropenem concentrations in blister fluid lagged behind peak meropenem concentrations in plasma, while a lower elimination rate from blister fluid was also noted. The mean penetration of meropenem into blister fluid was 67%. The pharmacokinetic profile of meropenem in blister fluid supports the utility of this dose in the management of skin and soft tissue infections.
9
Javier Garau, José Blanquer, L. Cobo et al. · European Journal of Clinical Microbiology & Infectious Diseases · 1997 · 57 citations
Meropenem pharmacokinetics and penetration into an inflammatory exudate
Robert A. Wise, M Logan, Melisa Cooper et al. · Antimicrobial Agents and Chemotherapy · 1990 · 54 citations · Full text